Stockreport

Tevogen Bio Announces Unique T Cell Vaccine Under Development and Files Patent with the USPTO [Yahoo! Finance]

Tevogen Bio Holdings Inc.  (TVGN) 
PDF to company's lead product candidate TVGN 489, to mitigate the risk posed by mutations. Approach may provide prophylaxis to viral infections and would be complementary [Read more]